Fulgent Genetics Inc (FLGT) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $21.69 (-0.73%), Market cap $0.46B, 52-week low–high $13.79 ~ $30.85.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencaps
Financial statements, price targets, institutional (13F) holdings and related news for Fulgent Genetics Inc are updated in real time on BlackAll Trade.
Fulgent Genetics Inc trades at $21.69 (-0.73%). Real-time quotes and charts are available on BlackAll Trade.
Fulgent Genetics Inc has a market cap of about $0.46B.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutio